- Location
Biocon
"-
Monoclonal Antibody Agents Have Been Successfully Used in The Treatment of Tumors
Dec 23, 2013Currently, monoclonal antibody agents have been successfully used in the treatment of tumors, cancers and other serious diseases as a heavyweight in the biopharmaceutical industry. In 2009-2012, the market size of monoclonal antibody agents ...
-
Biocon Is Sure Herceptin Biosimilar Version Will Be Launched This Year
Aug 26, 2013India-based Biocon is likely to launch the Swiss drugmaker Roche's Herceptin (trastuzumab) biosimilar version by the end of 31 March 2014, following the latter's decision to give up a patent fight over the breast cancer drug in the country. ...
-
Biocon Has Launched The First Anti-CD6 Monoclonal Antibody,Alzumab
Aug 15, 2013Biotechnology company Biocon has launched the first anti-CD6 monoclonal antibody, alzumab (Itolizumab), to treat patients with chronic plaque psoriasis in India. Indicated for the treatment of moderate-to-severe psoriasis, Alzumab is ...
-
PM Group Has Announced to Award a Design and Project Management Contract
Nov 28, 2012PM Group has announced that it has been awarded a design and project management contract for McCain Foods in India. The project involves the construction of a $69m food manufacturing facility in Ahmedabad, Gujarat. McCain Foods is a ...
-
Biocon Invests in Biocon Research Center to Conduct Research on Biologics
Apr 10, 2012Biocon has invested in new integrated research and development centre, Biocon Research Center (BRC), in South-East Asia to conduct research on biologics that will deal with unmet medical needs. The 200,000ft2 will accommodate the ...
Tags: Biocon, invested, BRC, research on biologics, South-East Asia
